We are live on ! Find out more
MNTA

Momenta Pharmaceuticals, Inc.
MNTA

Delisted

MNTA was delisted on the 30th of September, 2020.

Back to rankings

147 hedge funds and large institutions have $1.42B invested in Momenta Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 82 increasing their positions, 29 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

183% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 29

35% more capital invested

Capital invested by funds: $1.05B → $1.42B (+$370M)

7% less funds holding

Funds holding: 158 → 147 (-11)

21% less call options, than puts

Call options by funds: $834K | Put options by funds: $1.05M

44% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 25

Holders
147
Holders Change
-11
Holders Change %
-6.96%
% of All Funds
3.18%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
14
Increased
82
Reduced
29
Closed
25
Calls
$834K
Puts
$1.05M
Net Calls
-$216K
Net Calls Change
-$707K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$17.8M
2
Citadel Advisors
Citadel Advisors
Florida
+$8.42M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$7.57M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
+$7.28M
5
GPP
Great Point Partners
Connecticut
+$3.95M

Top Sellers

Rank Fund Capital Flow
1
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$5.74M
2
MIM
Monashee Investment Management
Massachusetts
-$3.86M
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$2.72M
4
SSA
Schonfeld Strategic Advisors
New York
-$2.69M
5
LCM
Laurion Capital Management
New York
-$2.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Ameriprise
26
Ameriprise
Minnesota
$8.05M +$91.8K +7,188 +1%
Goldman Sachs
27
Goldman Sachs
New York
$7.47M +$2.7M +211,588 +70%
GTC
28
Ghost Tree Capital
New York
$7.26M +$2.24M +175,000 +54%
RSCM
29
Rock Springs Capital Management
Maryland
$5.81M – – –
TA
30
Teachers Advisors
New York
$4.52M +$380K +29,762 +11%
GPP
31
Great Point Partners
Connecticut
$4.5M +$3.95M +309,564 New
JP Morgan Chase
32
JP Morgan Chase
New York
$4.08M +$267K +20,882 +8%
RhumbLine Advisers
33
RhumbLine Advisers
Massachusetts
$4.01M +$371K +29,032 +12%
Legal & General Group
34
Legal & General Group
United Kingdom
$3.84M +$573K +44,869 +20%
EDRH
35
Edmond de Rothschild Holding
Switzerland
$3.78M – – –
USAA
36
United Services Automobile Association
Texas
$3.15M -$68.2K -5,340 -2%
AQR Capital Management
37
AQR Capital Management
Connecticut
$2.93M -$1.85M -144,802 -42%
Squarepoint
38
Squarepoint
New York
$2.68M +$326K +25,542 +16%
TCIM
39
TIAA CREF Investment Management
New York
$2.51M -$1.11M -86,927 -33%
QI
40
QS Investors
New York
$2.51M – – –
California Public Employees Retirement System
41
California Public Employees Retirement System
California
$2.47M +$572K +44,800 +36%
Swiss National Bank
42
Swiss National Bank
Switzerland
$2.42M +$46K +3,600 +2%
Millennium Management
43
Millennium Management
New York
$2.35M -$1.24M -96,844 -37%
Prudential Financial
44
Prudential Financial
New Jersey
$2.27M +$45.1K +3,530 +2%
Two Sigma Advisers
45
Two Sigma Advisers
New York
$2.25M -$72.8K -5,700 -4%
ASRS
46
Arizona State Retirement System
Arizona
$2.21M +$52.7K +4,127 +3%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$2.17M +$396K +31,000 +26%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$2.17M +$350K +27,384 +22%
Macquarie Group
49
Macquarie Group
Australia
$2.06M – – –
AllianceBernstein
50
AllianceBernstein
Tennessee
$2.01M +$151K +11,800 +9%
1
2
3 4 5

MNTA Hedge Fund Activity: Q1 2019 in Review

147 of the 4,621 institutional investors tracked by Wall St. Rank reported a position in Momenta Pharmaceuticals, Inc. (MNTA) for Q1 2019, worth a combined $1.42B — up 35% from $1.05B a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of MNTA and 14 opened new positions — a net loss of 11 holders — while 29 trimmed existing stakes and 82 added.

The largest buyer was BlackRock, adding an estimated $17.8M. The largest seller was D.E. Shaw & Co, cutting an estimated $5.74M.

  • 147 institutional investors held Momenta Pharmaceuticals, Inc. (MNTA) as of Q1 2019, down from 158 in Q4 2018.
  • Funds reported $1.42B of Momenta Pharmaceuticals, Inc. stock for Q1 2019, up 35% quarter-over-quarter.
  • 14 funds opened new Momenta Pharmaceuticals, Inc. positions in Q1 2019 and 25 closed out, a net change of -11 holders.
  • The largest Momenta Pharmaceuticals, Inc. buyer in Q1 2019 was BlackRock, an estimated $17.8M added.
  • The largest Momenta Pharmaceuticals, Inc. seller in Q1 2019 was D.E. Shaw & Co, an estimated $5.74M sold.

Based on aggregated 13F filings for Q1 2019.